Surprisingly, however, TN/BL/BRCA1-IRIS-positive tumor size was significantly larger than that of HER2+/BRCA1-IRIS-positive tumors (30.6±19.3 vs. 16.1±9.7, p≤0.05). Here, ERBB2 is linked to neoplasm.